Department of Academic Pathology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Driskill Graduate Program in Life Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Cell Rep. 2023 Mar 28;42(3):112265. doi: 10.1016/j.celrep.2023.112265. Epub 2023 Mar 16.
Inflammatory responses are crucial for controlling infections and initiating tissue repair. However, excessive and uncontrolled inflammation causes inflammatory disease. Processing and release of the pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18 depend on caspase-1 activation within inflammasomes. Assembly of inflammasomes is initiated upon activation of cytosolic pattern recognition receptors (PRRs), followed by sequential polymerization of pyrin domain (PYD)-containing and caspase recruitment domain (CARD)-containing proteins mediated by homotypic PYD and CARD interactions. Small PYD- or CARD-only proteins (POPs and COPs, respectively) evolved in higher primates to target these crucial interactions to limit inflammation. Here, we show the ability of COPs to regulate inflammasome activation by modulating homotypic CARD-CARD interactions in vitro and in vivo. CARD16, CARD17, and CARD18 displace crucial CARD interactions between caspase-1 proteins through competitive binding and ameliorate uric acid crystal-mediated NLRP3 inflammasome activation and inflammatory disease. COPs therefore represent an important family of inflammasome regulators and ameliorate inflammatory disease.
炎症反应对于控制感染和启动组织修复至关重要。然而,过度和失控的炎症会导致炎症性疾病。前炎症细胞因子白细胞介素-1β(IL-1β)和 IL-18 的加工和释放依赖于炎性小体中半胱天冬酶-1 的激活。炎性小体的组装是在细胞质模式识别受体(PRRs)激活后启动的,随后通过同源性 PYD 和 CARD 相互作用介导含有吡喃结构域(PYD)和半胱氨酸天冬氨酸蛋白酶募集结构域(CARD)的蛋白的顺序聚合。在高等灵长类动物中进化出了小 PYD 或 CARD 仅蛋白(POPs 和 COPs),分别用于将这些关键相互作用靶向以限制炎症。在这里,我们展示了 COPs 通过在体外和体内调节同源 CARD-CARD 相互作用来调节炎性小体激活的能力。CARD16、CARD17 和 CARD18 通过竞争性结合置换半胱天冬酶-1 蛋白之间的关键 CARD 相互作用,改善尿酸晶体介导的 NLRP3 炎性小体激活和炎症性疾病。因此,COPs 代表了一类重要的炎性小体调节剂,可以改善炎症性疾病。